Skip to main content
. 2023 Mar 3;96(1145):20220803. doi: 10.1259/bjr.20220803

Table 1.

Tumor and Treatment Characteristics

Characteristics N %
T stage
 T1c 2 6.1
 T2a 10 30.3
 T2b 9 27.3
 T2c 8 24.2
 T3a 3 9.1
 T3b 1 3
Gleason Score
 3 + 3 3 9.1
 3+4 17 51.5
 4+3 5 15.2
 4+4 4 12.1
 3+5 1 3
 4+5 3 9.1
Low risk (GS < 6 and PSA < 10 and T1c/T2a) 1 3
Intermediaterisk(GS = 7 or PSA > 10 or ≤cT2a) 14 42.4
High risk (GS ≥ 8 or ≥cT2c or PSA > 20) 18 54.6
Hormonal therapy
 Yes 1 3
 No 32 97
Radiotherapy delivery
 CyberKnife 27 81.8
 Tomotherapy 3 9.1
 Synergy 3 9.1